Insider Transactions last 24 months for Rapport Therapeutics, Inc.  -  NSDQ: RAPP

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Gault CherylChief Operating Officer03/30/2026DSDirectCOM2,839$28.55$81,061.97159,914
Gault CherylChief Operating Officer03/30/2026DSDirectCOM7,161$28.04$200,795.16162,753
Yeleswaram KrishnaswamyChief Development Officer03/25/2026DSDirectCOM10,115$29.99$303,354.92286,876
Gault CherylChief Operating Officer03/05/2026DSDirectCOM2,014$28.93$58,265.02169,914
Bredt DavidChief Scientific Officer02/19/2026AMDirectCOM6,000$1.80$10,800.00393,075
Ceesay AbrahamChief Executive Officer02/18/2026DSIndirectCOM2,100$29.80$62,572.6520,729
Ceesay AbrahamChief Executive Officer02/18/2026DSIndirectCOM2,983$29.04$86,639.1522,829
Ceesay AbrahamChief Executive Officer02/18/2026DSDirectCOM2,281$29.80$67,969.92556,247
Ceesay AbrahamChief Executive Officer02/18/2026DSDirectCOM3,552$29.05$103,191.28558,528
Bredt DavidChief Scientific Officer02/17/2026DSDirectCOM2,200$29.59$65,107.68387,075
Bredt DavidChief Scientific Officer02/17/2026DSDirectCOM5,400$28.95$156,328.38389,275
Bredt DavidChief Scientific Officer02/17/2026DSDirectCOM900$28.02$25,218.99394,675
Ceesay AbrahamChief Executive Officer01/20/2026DSIndirectCOM5,083$26.11$132,737.4625,812
Ceesay AbrahamChief Executive Officer01/20/2026DSDirectCOM5,833$26.12$152,333.46562,080
Bredt DavidChief Scientific Officer01/15/2026DSDirectCOM200$27.40$5,480.00395,575
Bredt DavidChief Scientific Officer01/15/2026DSDirectCOM8,300$26.83$222,651.65395,775
Yeleswaram KrishnaswamyChief Development Officer12/31/2025DSDirectCOM2,840$30.05$85,342.00296,991
Yeleswaram KrishnaswamyChief Development Officer12/31/2025AADirectCOM9,000$0.00$0.00299,831
Bredt DavidChief Scientific Officer12/31/2025DSDirectCOM6,567$30.05$197,337.69404,075
Bredt DavidChief Scientific Officer12/31/2025DADirectCOM18,000$0.00$0.00410,642
Ceesay AbrahamChief Executive Officer12/17/2025DSIndirectCOM515$31.04$15,985.3930,895
Ceesay AbrahamChief Executive Officer12/17/2025DSIndirectCOM2,421$30.04$72,721.5131,410
Ceesay AbrahamChief Executive Officer12/17/2025DSIndirectCOM2,147$28.84$61,924.8533,831
Ceesay AbrahamChief Executive Officer12/17/2025DSDirectCOM600$31.04$18,621.60567,913
Ceesay AbrahamChief Executive Officer12/17/2025DSDirectCOM2,792$30.04$83,861.91568,513
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel